BHALLATAKA-INDUCED DERMAL TOXICITY AND ITS AYURVEDIC MANAGEMENT WITH DARU –SARSHAPA–MUSTA LEPA: A CRITICAL REVIEW

Bhallataka (Semecarpus anacardium) oil, while therapeutically potent in Ayurveda, presents significant dermal toxicity, manifesting as inflammation, irritation, and hypersensitivity. Modern dermatology links these effects to bioactive compounds that incite inflammatory and allergic reactions. Ayurveda attributes this to Bhallataka's inherent Ushna (hot), Tikshna (penetrating), and Katu (pungent) properties, which can aggravate Pitta and Vata doshas, leading to skin pathologies. To counteract these effects, the classical Ayurvedic formulation Daru-Sarshpa-Musta Lepa is traditionally recommended. This topical preparation comprises Cedrus deodara (Daru), Brassica campestris (Sarshpa), Cyperus rotundus (Musta), and Navnit (Indian butter). An analysis from a pathophysiological (Samprapti) perspective indicates that Bhallataka toxicity arises from excessive Pitta and Vata, Which vitiate Twak (skin) and Rakta (blood). The Lepa addresses this imbalance through its Shita (cooling), Snigdha (soothing), and Ropan (healing) properties, aiming to restore cutaneous homeostasis and facilitate detoxification. This synergistic Ayurvedic approach provides a natural alternative for managing Bhallataka-induced dermal conditions. While classical texts endorse its efficacy, further scientific validation is essential to integrate this formulation into modern dermatological practice. Standardizing its preparation and evaluating its pharmacological profile can pave the way for safer and more effective therapeutic applications.